Impairment of eNOS contributes to the pathological alterations in vascular reactivity and structure that are observed in atherosclerosis. The premise of the current proposal is that impairment of the NOS pathway also plays a major role in the development of TA. We propose that in transplant recipients, the endothelial NOS pathway is impaired by two major insults: 1) increases in vascular superoxide anion (O2-), and 2) increases in ADMA. These abnormalities increase NO degradation and reduce NO synthesis. We further hypothesize that CMV infection augments these abnormalities via cytokine induced alterations in oxidative stress and ADMA accumulation. Accordingly, we propose to characterize the derangement of the NOS pathway in TA. We will assess the activity of the NOS pathway in transplant recipients using coronary vascular reactivity studies, coronary arteriovenous gradients and tissue biopsy studies using markers, which reflect NOS activity and oxidative stress. Genomic DNA obtained from the biopsy material will be used to characterize polymorphisms of the NOS pathway that may be associated with specific phenotypes. In addition, biochemical and physiological measurements of traditional and non-traditional risk factors, viral load and strain identification of CMV will be performed. These studies should provide insights into the mechanisms by which the NOS pathway is disturbed, and the role of CMV in these perturbations. However, cardiac transplant recipients have multiple metabolic disturbances that may impair the NOS pathway. Furthermore, CMV infection may have indirect effects on endothelial function by activation of the immune response. Therefore, to determine if there are direct effects of CMV infection on endothelial NOS, and to delineate mechanisms, additional studies of the CMV/NOS interaction will be conducted in endothelial cell cultures to determine the role of ADMA and oxidative stress in CMV-induced alterations in endothelial NOS and determinants of endothelial-mononuclear cell interaction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI050153-01
Application #
6546923
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2001-09-10
Project End
2006-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Yang, Hyoung-Mo; Khush, Kiran; Luikart, Helen et al. (2016) Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation. Circulation 133:1945-50
Okada, Kozo; Fearon, William F; Luikart, Helen et al. (2016) Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. J Am Coll Cardiol 68:382-92
Okada, Kozo; Kitahara, Hideki; Yang, Hyoung-Mo et al. (2015) Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation. JACC Heart Fail 3:942-52
Haddad, François; Khazanie, Prateeti; Deuse, Tobias et al. (2012) Clinical and functional correlates of early microvascular dysfunction after heart transplantation. Circ Heart Fail 5:759-68
Yamasaki, Masao; Sakurai, Ryota; Hirohata, Atsushi et al. (2011) Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis. Transplantation 91:1406-11
Holweg, Cécile T J; Potena, Luciano; Luikart, Helen et al. (2011) Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation 123:2236-43
Tu, Wenwei; Lau, Yu-Lung; Zheng, Jian et al. (2008) Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 112:2554-62
Sinha, Seema S; Pham, Michael X; Vagelos, Randall H et al. (2008) Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. Am Heart J 155:889.e1-6
Potena, Luciano; Fearon, William F; Sydow, Karsten et al. (2008) Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Transplantation 85:827-33
Sydow, Karsten; Mondon, Carl E; Schrader, Joerg et al. (2008) Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 28:692-7

Showing the most recent 10 out of 56 publications